2nd Quarter - Report

THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) for THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$1,890,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 21, 2025 $1,890,000 Replaced
2nd Quarter - Amendment Oct 20, 2025 $1,930,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

P.L. 117-169, the Inflation Reduction Act of 2022; H.R. 4189/S. 2016, The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023; Issues related to transparency and prior authorization.

LobbyistCovered position, as disclosed
CHRISTOPHER HARTMANN —
COURTNEY LAWRENCE —
KARA SMITH New Deputy Chief of Staff and Legislative Director, Sen. Kit Bond

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 4189 (119th), S. 2016 (119th)

Health Issues HCR

S. 864/H.R. 247, the Health Care Affordability Act of 2025 and issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) including in the American Rescue Plan Act (ARPA) and the Inflation Reduction Act (IRA); Issues related to P.L.119-21 (H.R. 1), the One Big Beautiful Bill Act, and budget reconciliation; Issues related to H.R. 2041, the Hidden Fee Disclosure Act of 2025.

LobbyistCovered position, as disclosed
BRENDAN DEVINE —
KATHRYN GALLAGHER —
CHRISTOPHER HARTMANN —
COURTNEY LAWRENCE —
JULIEN MITCHELL RELFE —
KARA SMITH New Deputy Chief of Staff and Legislative Director, Sen. Kit Bond

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (119th), H.R. 2041 (119th), H.R. 247 (119th), S. 864 (119th)

Defense DEF

Pharmacy issues related to the National Defense Authorization Act, FY2026.

LobbyistCovered position, as disclosed
BRENDAN DEVINE —
CHRISTOPHER HARTMANN —
JULIEN MITCHELL RELFE —
KARA SMITH New Deputy Chief of Staff and Legislative Director, Sen. Kit Bond

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

S. 1542/H.R.2214, the DRUG Act; H.R. 5378 Lower Costs, More Transparency Act; S. 1339, Pharmacy Benefit Manager Reform Act; S.526, Pharmacy Benefit Manager Transparency Act; S. 1040, The Drug Competition and Enhancement Act; S. 1041, The Affordable Prescriptions for Patients Act; Issues related to the specialty drug market.

LobbyistCovered position, as disclosed
BRENDAN DEVINE —
KATHRYN GALLAGHER —
CHRISTOPHER HARTMANN —
COURTNEY LAWRENCE —
JULIEN MITCHELL RELFE —
KARA SMITH New Deputy Chief of Staff and Legislative Director, Sen. Kit Bond

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: S. 1542 (119th), H.R. 5378 (119th), S. 1040 (119th), S. 526 (119th), S. 1041 (119th), H.R. 2214 (119th), S. 1339 (119th)

Labor Issues/Antitrust/Workplace LBR

Issues related to competition in the health care marketplace.

LobbyistCovered position, as disclosed
BRENDAN DEVINE —
CHRISTOPHER HARTMANN —
KARA SMITH New Deputy Chief of Staff and Legislative Director, Sen. Kit Bond

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.